Rchr
J-GLOBAL ID:202201008799447446
Update date: Mar. 19, 2024 Fujii Kiyonaga
フジイ キヨナガ | Fujii Kiyonaga
Affiliation and department: Job title:
Professor
Research field (1):
Pharmaceuticals - analytical and physicochemistry
Research keywords (5):
分離科学
, 質量分析
, プロテオミクス
, バイオマーカー
, 天然物化学
Research theme for competitive and other funds (7): Papers (81): -
Takayuki Koga, Kie Inoue, Fuka Hirayama, Makoto Hiromura, Kiyonaga Fujii, Yuji Ishii, Masayo Hirao-Suzuki, Shuso Takeda, Akihisa Toda, Fumio Soeda. Dimethylglycine, a methionine metabolite, participates in the suppressive effect of methionine on 1-fluoro-2,4-dinitrobenzene-induced dermatitis. Biological & pharmaceutical bulletin. 2023
-
Genki Sakai, Masayo Hirao-Suzuki, Takayuki Koga, Takananobu Kobayashi, Jun Kamishikiryo, Michitaka Tanaka, Kiyonaga Fujii, Masufumi Takiguchi, Narumi Sugihara, Akihisa Toda, et al. Perfluorooctanoic acid (PFOA) as a stimulator of estrogen receptor-negative breast cancer MDA-MB-231 cell aggressiveness: Evidence for involvement of fatty acid 2-hydroxylase (FA2H) in the stimulated cell migration. Journal of Toxicological Sciences. 2022. 47. 4. 159-168
-
Hiroki Sakai, Hiroyuki Kimura, Kanji Otsubo, Tomoyuki Miyazawa, Hideki Marushima, Koji Kojima, Motohiro Chosokabe, Naoki Furuya, Junki Koike, Kiyonaga Fujii, et al. Minichromosome maintenance 2 is an independent predictor of survival in patients with lung adenocarcinoma. Molecular and Clinical Oncology. 2022. 16. 1. 22-22
-
Toshihide Nishimura, Kiyonaga Fujii, Haruhiko Nakamura, Saeko Naruki, Hiroki Sakai, Hiroyuki Kimura, Tomoyuki Miyazawa, Masayuki Takagi, Naoki Furuya, Gyorgy Marko-Varga, et al. Protein co-expression network-based profiles revealed from laser-microdissected cancerous cells of lung squamous-cell carcinomas. Scientific Reports. 2021. 11. 1. 20209-20209
-
Hidetomo Yokoo, Norihito Shibata, Akinori Endo, Takahito Ito, Yuta Yanase, Yuki Murakami, Kiyonaga Fujii, Kengo Hamamura, Yasushi Saeki, Mikihiko Naito, et al. Discovery of a Highly Potent and Selective Degrader Targeting Hematopoietic Prostaglandin D Synthase via in Silico Design. Journal of Medicinal Chemistry. 2021. 64. 21. 15868-15882
more... MISC (3): -
田村奈月美, 小西純, 藤井清永, 浜村賢吾, 横尾英知, 柴田識人, 内藤幹彦, 出水庸介, 有竹浩介. 造血器型プロスタグランジンD合成酵素分解誘導薬の創出-酵素阻害薬に対する優位性について-. 日本薬学会九州山口支部大会講演要旨集(CD-ROM). 2023. 40th
-
柴田識人, 横尾英知, 遠藤彬則, 伊藤貴仁, 柳瀬雄太, 柳瀬雄太, 村上優貴, 村上優貴, 藤井清永, 近藤一成, et al. Development of a selective degrader targeting hematopoietic prostaglandin D synthase. 日本薬学会年会要旨集(Web). 2022. 142nd
-
横尾 英知, 柴田 識人, 永沼 美弥子, 村上 優貴, 藤井 清永, 伊藤 貴仁, 有竹 浩介, 内藤 幹彦, 出水 庸介. 造血器型プロスタグランジンD合成酵素分解誘導剤の開発. 日本薬学会年会要旨集. 2021. 141年会. 28V06-am11
Education (2): - - 1995 Meijo University Graduate School of Pharmacy
- - 1993 Meijo University Faculty of Pharmacy Department of Pharmacy
Professional career (2): - Ph. D. (The University of Tokushima)
- Master of Pharmaceutical Sciences (Meijo University)
Work history (8): - 2019 - Daiichi University of Pharmacy
- 2016 - St.Marianna University School of Medicine
- 2013 - Asahikawa Medical University
- 2006 - Hokkaido University Faculty of Pharmaceutical Sciences
- 2005 - National Cancer Center
- 2003 - Tokyo Medical University
- 2002 - マウントサイナイ医科大学 博士研究員
- 1995 - Meijo University Faculty of Pharmacy
Show all
Association Membership(s) (4):
日本分析学会
, 日本癌学会
, 日本質量分析学会
, 日本薬学会
Return to Previous Page